US sues Re­gen­eron over ‘hun­dreds of mil­lions’ in al­leged­ly in­flat­ed Medicare re­im­burse­ments for Eylea

Re­gen­eron Phar­ma­ceu­ti­cals has been ac­cused of ma­nip­u­lat­ing Medicare re­im­burse­ment for its eye drug Eylea. If found li­able, the com­pa­ny could end up pay­ing three times the amount that Medicare lost — which was es­ti­mat­ed at “hun­dreds of mil­lions of dol­lars” — plus po­ten­tial penal­ties, the gov­ern­ment said.

On April 10, the US at­tor­ney’s of­fice in the Dis­trict of Mass­a­chu­setts said it filed a com­plaint against Re­gen­eron un­der the False Claims Act at a fed­er­al court in Boston.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.